Patent · US Active

Stable aqueous formulations of adalimumab

US9861695B2 · kind B2 · utility

31Cited by
26References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 23, 2016
Grant dateJan 9, 2018
Priority date—
Expiry dateNov 23, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these compositions, methods of administration, and kits containing same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.